We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$22B
AUM Growth
-$123M
Cap. Flow
-$1.19B
Cap. Flow %
-5.42%
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$62M
2
UBS icon
UBS Group
UBS
+$49.7M
3
APD icon
Air Products & Chemicals
APD
+$47.3M
4
T icon
AT&T
T
+$44.6M
5
LRCX icon
Lam Research
LRCX
+$39.6M

Top Sells

Rank Stock Value
1
HPE icon
Hewlett Packard
HPE
+$61.6M
2
HCA icon
HCA Healthcare
HCA
+$50.8M
3
GEN icon
Gen Digital
GEN
+$50.7M
4
BAX icon
Baxter International
BAX
+$50.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$49.1M

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Healthcare 16.24%
3 Financials 11.47%
4 Consumer Discretionary 9.38%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWST icon
1076
Casella Waste Systems
CWST
$5.76B
$372K ﹤0.01%
22,690
+4,500
+25% +$66.5K
BKF icon
1077
iShares MSCI BIC ETF
BKF
$77M
$371K ﹤0.01%
9,916
KKR icon
1078
KKR & Co
KKR
$89.1B
$371K ﹤0.01%
19,941
PDS
1079
Precision Drilling
PDS
$946M
$371K ﹤0.01%
5,436
EWM icon
1080
iShares MSCI Malaysia ETF
EWM
$307M
$364K ﹤0.01%
+11,464
New +$365K
SNCR
1081
DELISTED
Synchronoss Technologies
SNCR
$364K ﹤0.01%
2,457
-9,603
-80% -$1.43M
ESL
1082
DELISTED
Esterline Technologies
ESL
$360K ﹤0.01%
+3,800
New +$353K
RSYS
1083
DELISTED
Radisys Corp
RSYS
$360K ﹤0.01%
95,800
SLCA
1084
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$355K ﹤0.01%
+10,000
New +$394K
HVT icon
1085
Haverty Furniture Companies
HVT
$418M
$354K ﹤0.01%
14,090
PLPC icon
1086
Preformed Line Products
PLPC
$1.39B
$353K ﹤0.01%
7,601
-7,048
-48% -$348K
PFG icon
1087
Principal Financial Group
PFG
$24.3B
$350K ﹤0.01%
5,465
-202,800
-97% -$12.9M
SKM icon
1088
SK Telecom
SKM
$11.4B
$344K ﹤0.01%
8,142
HBP
1089
DELISTED
Huttig Building Products, Inc.
HBP
$344K ﹤0.01%
49,140
MXIM
1090
DELISTED
Maxim Integrated Products
MXIM
$341K ﹤0.01%
7,583
+400
+6% +$18.4K
LION
1091
DELISTED
Fidelity Southern Corporation
LION
$338K ﹤0.01%
14,800
TUR icon
1092
iShares MSCI Turkey ETF
TUR
$201M
$336K ﹤0.01%
8,084
LPL icon
1093
LG Display
LPL
$2.79B
$335K ﹤0.01%
20,845
+2,474
+13% +$35.2K
UPBD icon
1094
Upbound Group
UPBD
$1.22B
$335K ﹤0.01%
+28,600
New +$323K
IXC icon
1095
iShares Global Energy ETF
IXC
$2.75B
$333K ﹤0.01%
10,730
-6,204
-37% -$201K
NNN icon
1096
NNN REIT
NNN
$9.29B
$331K ﹤0.01%
+8,468
New +$342K
CPT icon
1097
Camden Property Trust
CPT
$11.5B
$329K ﹤0.01%
+3,843
New +$322K
TEL icon
1098
TE Connectivity
TEL
$60B
$325K ﹤0.01%
4,132
+740
+22% +$56.6K
IMKTA icon
1099
Ingles Markets
IMKTA
$1.72B
$323K ﹤0.01%
9,700
-12,800
-57% -$508K
EPOL icon
1100
iShares MSCI Poland ETF
EPOL
$680M
$318K ﹤0.01%
13,100
+1,100
+9% +$25.8K

Similar funds

Axa's Q2 2017 Portfolio in Review

As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Element Solutions worth $22.3M.

  • Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
  • Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
  • Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
  • Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
  • Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
  • Axa opened 101 new positions and closed 125 in Q2 2017.
  • Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.

Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.